Wegovy vs Mounjaro: The Complete UK Buyer's Comparison Guide
Is Wegovy or Mounjaro Better For Weight Loss: Understanding Your Online Purchase Options
When determining whether Wegovy or Mounjaro is better for weight loss, UK patients benefit from understanding the distinct advantages of each prescription-only medicine. Wegovy contains semaglutide, a GLP-1 receptor agonist that works by mimicking natural fullness hormones to reduce appetite and promote satiety after smaller meals. Mounjaro contains tirzepatide, a dual-action treatment that targets both GIP and GLP-1 receptors, offering a different approach to appetite regulation and glucose control.
The question of whether Wegovy or Mounjaro is better for weight loss depends largely on individual response patterns and tolerability profiles. Through EverydayMeds' online service, patients can access both treatments following a comprehensive 3-minute clinical assessment and prescriber review. Our GPhC #9012878 registered pharmacy ensures genuine medications from Novo Nordisk (Wegovy) and Eli Lilly (Mounjaro), delivered via next-day cold-chain logistics to maintain therapeutic efficacy.
Pricing Comparison: Wegovy vs Mounjaro Costs When You Buy Online UK
Understanding the cost implications when deciding if Wegovy or Mounjaro is better for weight loss requires examining both treatments' pricing structures. Wegovy begins at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. New customers apply discount code FIRST40 at checkout, whilst returning patients use code DOSE25 to access these competitive rates.
Mounjaro follows a different pricing model, reflecting its dual-hormone mechanism and newer market position. When comparing whether Wegovy or Mounjaro is better for weight loss from a value perspective, consider that Wegovy's pricing reflects five years of UK market presence and established supply chains. Bundle options like the Intro Duo (0.25mg & 0.5mg) at £169.99 or Ultimate Stability Trio (three 2.4mg pens) at £649.99 provide convenient multi-month supplies with Stock Available availability.
Clinical Evidence: Which Treatment Shows Better Weight Loss Results?
Clinical trials provide insight into whether Wegovy or Mounjaro performs better for weight loss, though direct comparisons require careful interpretation. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial demonstrated an additional 20% reduction in major cardiovascular events.
Mounjaro's SURMOUNT trials showed promising results using the same rigorous methodology, though different study populations and endpoints make direct percentage comparisons inappropriate. When determining if Wegovy or Mounjaro is better for weight loss, patients should focus on individual suitability rather than trial-to-trial comparisons, as both treatments demonstrated significant efficacy when used alongside reduced-calorie diets and increased physical activity.
How Wegovy Works: The Science Behind GLP-1 Weight Loss
Understanding Wegovy's mechanism helps clarify whether Wegovy or Mounjaro might be better for your weight loss journey. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of naturally occurring incretin hormones released after eating. This medication works primarily by slowing gastric emptying, which prolongs feelings of fullness and reduces the urge to eat between meals. Additionally, Wegovy acts on appetite centres in the brain, potentially reducing food cravings and the psychological drive to consume calorie-dense foods. The once-weekly FlexTouch injection provides consistent therapeutic levels, eliminating daily dosing requirements that can affect treatment adherence.
Simple Online Ordering: Your Path to Wegovy or Mounjaro Treatment
Accessing either treatment through EverydayMeds follows a streamlined three-step process designed for busy UK patients. Begin with our 3-minute online clinical assessment, covering medical history, current medications, and weight management goals to help determine whether Wegovy or Mounjaro might be better suited to your circumstances. Our prescribers review applications within 3 working days (or 24 hours with express service), ensuring thorough evaluation of your suitability for either treatment. Once approved, next-day delivery via temperature-controlled logistics ensures your chosen medication arrives in optimal condition, ready for immediate use following the prescribed dosing schedule.
Storage and Practical Considerations: Wegovy vs Mounjaro Convenience
Practical factors often influence whether Wegovy or Mounjaro proves better for individual lifestyles, particularly regarding storage requirements and travel considerations. Wegovy offers superior storage flexibility, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both treatments require refrigerated storage (2-8°C) before first use and utilise pre-filled injection pens for convenient self-administration. The weekly injection schedule for both medications eliminates daily dosing concerns, though Wegovy's established dose escalation protocol (0.25mg→0.5mg→1mg→1.7mg→2.4mg over 16 weeks) provides well-documented tolerability data. The FlexTouch delivery system used by Wegovy has been refined through years of patient feedback, ensuring reliable dose delivery with minimal injection site reactions.
Dual-Hormone vs Single-Hormone: Is Wegovy or Mounjaro Better for Complex Cases?
Patients with multiple metabolic concerns often wonder whether Wegovy or Mounjaro offers better comprehensive benefits beyond weight loss. Mounjaro's dual-action mechanism targeting both GIP and GLP-1 receptors may provide additional glucose regulation benefits, potentially advantageous for patients with prediabetes or metabolic syndrome. However, Wegovy's established safety profile and extensive real-world usage data spanning five years offer reassurance for long-term treatment planning.
The cardiovascular benefits demonstrated in Wegovy's SELECT trial represent a significant advantage for patients with existing heart disease risk factors. When considering whether Wegovy or Mounjaro is better for weight loss in complex medical situations, our prescribers evaluate individual risk profiles, concurrent medications, and treatment goals to recommend the most appropriate option.
Start Your Weight Loss Journey: Wegovy Available from £79.99
Rather than continuing to wonder whether Wegovy or Mounjaro is better for weight loss, take the first step by completing our clinical assessment at https://everydaymeds.co.uk/collections/wegovy. New customers save with discount code FIRST40, while returning patients use DOSE25 at checkout for competitive pricing on genuine treatments. Our experienced clinical team provides ongoing support throughout your weight management journey, helping optimise results and manage any side effects. Both treatments are available through our GPhC #9012878 registered service, ensuring professional oversight and authentic medications delivered directly to your door. Weight management success requires commitment to long-term lifestyle changes, and our prescribers ensure you have the clinical support necessary for sustainable results.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
